Technische Universität München
Stories about Effector (biology)
-
Language:
English
-
Media:
All
- Period:
- Period:Total
- more
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
moreBreakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
moreData From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
moreERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
moreNew Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
moreProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
moreMerck Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Care
more
1